News

Laboratory Corporation of America® Holdings announced that Covance Drug Development (Covance) has launched Mobile Health Solutions, a suite of new capabilities designed to help biopharmaceutical and technology companies navigate the rapidly evolving mobile health landscape. Covance’s Mobile Health Solutions...

Reddy’s Laboratories Ltd. and TR-Pharm announced a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialized as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture...

Teva Pharmaceutical Industries Ltd. announced that it has received regulatory approval from the European Commission for its acquisition of Allergan plc’s global generics business. As part of the approval, Teva has agreed to the divestment of...

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners today announced the formation of Outpost Medicine, a biopharmaceutical company focused on the development of new treatments of urologic and gynecologic diseases and disorders. In exchange for undisclosed...

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and TR-Pharm announced today a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialized as a part of this agreement...

H. Lundbeck A/S announced that the investigational compound Lu AF35700, a novel antipsychotic, is entering clinical phase III program. Lundbeck is initiating the phase III program which is currently planned to consist of two pivotal trials....

Irritable bowel syndrome (IBS) refers to a complex disorder of the lower intestinal tract. It is mainly characterized by a pattern of symptoms that is often worsened by emotional stress. It is not the same as inflammatory bowel disease...